These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 33712036)
1. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study. Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study. Yan Y; Qiao L; Hua Y; Shao S; Zhang N; Wu M; Liu L; Zhou K; Liu X; Wang C Pediatr Rheumatol Online J; 2021 Sep; 19(1):147. PubMed ID: 34563210 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study. Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782 [TBL] [Abstract][Full Text] [Related]
4. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China. Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833 [TBL] [Abstract][Full Text] [Related]
5. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease. Lu Y; Chen T; Wen Y; Si F; Wu X; Yang Y BMC Pediatr; 2021 Sep; 21(1):406. PubMed ID: 34530763 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients. Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545 [TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease. Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779 [TBL] [Abstract][Full Text] [Related]
9. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children. Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study. Shao S; Yang L; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Luo L; Zhou K; Wang C Pediatr Allergy Immunol; 2021 Aug; 32(6):1349-1359. PubMed ID: 33694279 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy. Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies. Liu J; Chen X; Yang M; Shen F; Zhu F; Jin J; Teng Y Pediatr Rheumatol Online J; 2024 Apr; 22(1):42. PubMed ID: 38610057 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Sato S; Kawashima H; Kashiwagi Y; Hoshika A Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640 [TBL] [Abstract][Full Text] [Related]
14. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance]. Li SY; Ding Y Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157 [TBL] [Abstract][Full Text] [Related]
15. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705 [TBL] [Abstract][Full Text] [Related]
16. Hibiscus score: Developing and validating a predictive tool for intravenous immunoglobulin treatment resistance in Malaysian children with Kawasaki disease. Tan JYC; Ng SY; Chan HK; Wong PM; Mohamed Zabidi H; Abu Hassan MR J Cardiol; 2024 Dec; 84(6):362-365. PubMed ID: 38852775 [TBL] [Abstract][Full Text] [Related]
17. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study. Nandi A; Pal P; Basu S Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740 [TBL] [Abstract][Full Text] [Related]
18. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study. Iwashima S; Kimura M; Ishikawa T; Ohzeki T Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105 [TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease. Huang XB; Zhao S; Liu ZY; Xu YY; Deng F Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383 [TBL] [Abstract][Full Text] [Related]
20. Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease. Liu X; Shao S; Zhang N; Wu M; Liu L; Duan H; Liu Z; Zhou K; Hua Y; Wang C Int Immunopharmacol; 2022 Sep; 110():108986. PubMed ID: 35764015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]